BMJ Best Practice

参考文献

关键文献

Richards BW, Jones FR Jr, Younge BR. Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves. Am J Ophthalmol. 1992;113:489-496.

Erman AB, Kejner AE, Hogikyan ND, et al. Disorders of cranial nerves IX and X. Semin Neurol. 2009;29:85-92.

Afifi AK, Bergman RA. Functional neuroanatomy: text and atlas. 2nd ed. New York, NY: McGraw-Hill; 2005.

Newman NJ, Dickersin K, Kaufman D, et al. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996;114:1366-1374.

Optic Neuritis Study Group. The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991;109:1673-1678.

Ayberk G, Özveren MF, Yildirim T, et al. Review of a series with abducens nerve palsy. Turk Neurosurg. 2008;18:366-373.

Sweeney PJ, Hanson MR. The cranial neuropathies. In Bradley WG, Daroff RB, Fenichel GM, et al, eds. Neurology in clinical practice: principles of diagnosis and management. 2nd ed. Boston, MA: Butterworth-Heinemann; 1996:1721-1732.

Jacobson DM, Trobe JD. The emerging role of magnetic resonance angiography in the management of patients with third cranial nerve palsy. Am J Ophthalmol. 1999;128:94-96.

参考文章

1.  Moran DT, Rowley JC 3rd, Jafek BW, et al. The fine structure of the olfactory mucosa in man. J Neurocytol. 1982;11:721-746.

2.  Doty RL. The olfactory system and its disorders. Semin Neurol. 2009;29:74-81.

3.  Gottfried JA, Deichmann R, Winston JS, et al. Functional heterogeneity in human olfactory cortex: an event-related functional magnetic resonance imaging study. J Neurosci. 2002;22:10819-10828.

4.  Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav. 1984;32:489-502.

5.  Selhorst JB, Chen Y. The optic nerve. Semin Neurol. 2009;29:29-35.

6.  Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol. 1990;300:5-25.

7.  Brazis PW. Isolated palsies of cranial nerves III, IV, and VI. Semin Neurol. 2009;29:14-28.

8.  Holmes JM, Mutyala S, Maus TL, et al. Pediatric third, fourth, and sixth nerve palsies: a population-based study. Am J Ophthalmol. 1999;127:388-392.

9.  Richards BW, Jones FR Jr, Younge BR. Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves. Am J Ophthalmol. 1992;113:489-496.

10.  Nemzek WR. The trigeminal nerve. Top Magn Reson Imaging. 1996;8:132-154.

11.  Erman AB, Kejner AE, Hogikyan ND, et al. Disorders of cranial nerves IX and X. Semin Neurol. 2009;29:85-92.

12.  Snell RS. Clinical neuroanatomy. Philadelphia, PA: Lippincott Williams & Wilkins; 2001.

13.  Remley KB, Harnsberger HR, Smoker WR, et al. CT and MRI in the evaluation of glossopharyngeal, vagal, and spinal accessory neuropathy. Semin Ultrasound CT MR. 1987;8:284-300.

14.  Afifi AK, Bergman RA. Functional neuroanatomy: text and atlas. 2nd ed. New York, NY: McGraw-Hill; 2005.

15.  Castillo M, Mukherji SK. Magnetic resonance imaging of cranial nerves IX, X, XI, and XII. Top Magn Reson Imaging. 1996;8:180-186.

16.  Parent A. Carpenter's human neuroanatomy. 9th ed. Baltimore, MD: Lippincott Williams & Wilkins; 1996.

17.  Massey EW. Spinal accessory nerve lesions. Semin Neurol. 2009;29:82-84.

18.  Warwick R, Williams PL. Gray's anatomy. 35th ed. Philadelphia, PA: WB Saunders; 1973.

19.  Lalwani AK. Current diagnosis and treatment in otolaryngology: head and neck surgery. 2nd ed. New York, NY: McGraw-Hill; 2007.

20.  Deems DA, Doty RL, Settle RG, et al. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg. 1991;117:519-528.

21.  Doty RL, Li C, Mannon LJ, et al. Olfactory dysfunction in multiple sclerosis. N Engl J Med. 1997;336:1918-1919.

22.  Schwob JE, Szumowski KE, Leopold DA, et al. Histopathology of olfactory mucosa in Kallmann's syndrome. Ann Otol Rhinol Laryngol. 1993;102:117-122.

23.  Newman NJ, Dickersin K, Kaufman D, et al. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996;114:1366-1374.

24.  Hayreh SS, Joos KM, Podhajsky PA, et al. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994;118:766-780.

25.  Stiebel-Kalish H, Hasanreisoglu M, Leibovici L. Aspirin following non-arteritic ischaemic optic neuropathy - a systematic review and meta-analysis. Neuro-Ophthalmol. 2010;34:14-19.

26.  Repka MX, Savino PJ, Schatz NJ, et al. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol. 1983;96:478-483.

27.  Nagel MA, Bennett JL, Khmeleva N, et al. Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis. Neurology. 2013;80:2017-2021.

28.  Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final Optic Neuritis Treatment Trial follow-up. Arch Neurol. 2008;65:727-732.

29.  Optic Neuritis Study Group. The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991;109:1673-1678.

30.  Beck RW, Gal RL, Bhatti MT, et al. Visual function more than 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. Am J Ophthalmol. 2004;137:77-83.

31.  Noble MJ, McFadzean R. Indirect injury to the optic nerves and optic chiasm. Neuroophthalmology. 1987;7:341-348.

32.  Borit A, Richardson EP Jr. The biological and clinical behaviour of pilocytic astrocytomas of the optic pathways. Brain. 1982;105:161-187.

33.  Newman NJ, Lott MT, Wallace DC. The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol. 1991;111:750-762.

34.  Newman NJ. Optic neuropathy. Neurology. 1996;46:315-322.

35.  Renowden SA, Harris KM, Hourihan MD. Isolated atraumatic third nerve palsy: clinical features and imaging techniques. Br J Radiol. 1993;66:1111-1117.

36.  Lee AG, Onan HW, Brazis PW, et al. An imaging guide to the evaluation of third cranial nerve palsies. Strabismus. 1999;7:153-168.

37.  Baker RS, Epstein AD. Ocular motor abnormalities from head trauma. Surv Ophthalmol. 1991;35:245-267.

38.  Neetens A, Van Aerde F. Extra-ocular muscle palsy from minor head trauma: initial sign of intracranial tumour. Bull Soc Belge Ophtalmol. 1981;193:161-167.

39.  Bijlsma MW, Brouwer MC, Kasanmoentalib ES, et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis. 2016;16:339-347.

40.  Anwar S, Nalla S, Fernando DJ. Abducens nerve palsy as a complication of lumbar puncture. Eur J Intern Med. 2008;19:636-637.

41.  Ayberk G, Özveren MF, Yildirim T, et al. Review of a series with abducens nerve palsy. Turk Neurosurg. 2008;18:366-373.

42.  Davies GE, Shakir RA. Giant cell arteritis presenting as oculomotor nerve palsy with pupillary dilatation. Postgrad Med J. 1994;70:298-299.

43.  Rush JA, Younge BR. Paralysis of cranial nerves III, IV, and VI: cause and prognosis in 1,000 cases. Arch Ophthalmol. 1981;99:76-79.

44.  Galbraith RS. Incidence of neonatal sixth nerve palsy in relation to mode of delivery. Am J Obstet Gynecol. 1994;170:1158-1159.

45.  Donahue SP, Taylor RJ. Pupil-sparing third nerve palsy associated with sildenafil citrate (Viagra). Am J Ophthalmol. 1998;126:476-477.

46.  Migita DS, Devereaux MW, Tomsak RL. Cocaine and pupillary-sparing oculomotor nerve paresis. Neurology. 1997;49:1466-1467.

47.  Bennetto L, Patel NK, Fuller G. Trigeminal neuralgia and its management. BMJ. 2007;334:201-205.

48.  Krafft RM. Trigeminal neuralgia. Am Fam Physician. 2008;77:1291-1296.

49.  Prasad S, Galetta SL. The trigeminal nerve. In: Goetz CG, ed. Textbook of clinical neurology. Philadelphia, PA: Saunders; 2007:165-184.

50.  Siccoli MM, Bassetti CL, Sandor PS. Facial pain: clinical differential diagnosis. Lancet Neurol. 2006;5:257-267.

51.  Rosenbaum R. Neuromuscular complications of connective tissue diseases. Muscle Nerve. 2001;24:154-169.

52.  Gilchrist JM. Seventh cranial neuropathy. Semin Neurol. 2009;29:5-13.

53.  Murakami S, Mizobuchi M, Nakashiro Y, et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;12427-12430.

54.  Sweeney CJ, Gilden DH. Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry. 2001;71:149-154.

55.  Kvestad E, Kvaerner KJ, Mair IW. Otologic facial palsy: etiology, onset, and symptom duration. Ann Otol Rhinol Laryngol. 2002;111:598-602.

56.  Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology. 1985;35:47-53.

57.  Pihlamaa T, Salmi T, Suominen S, et al. Progressive cranial nerve involvement and grading of facial paralysis in gelsolin amyloidosis. Muscle Nerve. 2016;53:762-769.

58.  Shambaugh GE Jr, Clemis JD. Facial nerve paralysis. In: Paparella MM, Shumrick DA, eds. Otolaryngology, vol 2. Philadelphia, PA: Saunders; 1973:275.

59.  Baloh RW. Clinical practice: vestibular neuritis. N Engl J Med. 2003;348:1027-1032.

60.  Shirley SG, Folmer RL, McMenomey SO. Tinnitus and hyperacusis. In: Cummings CW, Flint PW, Harker LA, et al, eds. Cummings otolaryngology: head and neck surgery, vol 4. 4th ed. Philadelphia, PA: Elsevier Saunders; 2005:354-355, 2832-3243.

61.  De Simone R, Ranieri A, Bilo L, et al. Cranial neuralgias: from physiopathology to pharmacological treatment. Neurol Sci. 2008;29(suppl 1):S69-S78.

62.  Mulpuru SK, Vasavada BC, Punukollu GK, et al. Cardiovocal syndrome: a systematic review. Heart Lung Circ. 2008;17:1-4.

63.  Massey EW, Heyman A, Utley C, et al. Cranial nerve paralysis following carotid endarterectomy. Stroke. 1984;15:157-159.

64.  Sweeney PJ, Hanson MR. The cranial neuropathies. In Bradley WG, Daroff RB, Fenichel GM, et al, eds. Neurology in clinical practice: principles of diagnosis and management. 2nd ed. Boston, MA: Butterworth-Heinemann; 1996:1721-1732.

65.  Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805-815.

66.  Frisen L, Royt WF, Tengroth BM. Optociliary veins, disc pallor and visual loss: a triad of signs indicating spheno-orbital meningioma. Acta Ophthalmol (Copenh). 1973;51:241-249.

67.  Balcer LJ, Galetta SL, Bagley LJ, et al. Localization of traumatic oculomotor nerve palsy to the midbrain exit site by magnetic resonance imaging. Am J Ophthalmol. 1996;122:437-439.

68.  Jacobson DM, Trobe JD. The emerging role of magnetic resonance angiography in the management of patients with third cranial nerve palsy. Am J Ophthalmol. 1999;128:94-96.

69.  Miller NR. Unequal pupils can be seen in diabetic 3rd nerve palsy. Evid Based Eye Care. 1999;1:40-41.

70.  Kim JH, Hwang JM, Hwang YS, et al. Childhood ocular myasthenia gravis. Ophthalmology. 2003;110:1458-1462.

71.  Moster ML, Savino PJ, Sergott RC, et al. Isolated sixth-nerve palsies in younger adults. Arch Ophthalmol. 1984;102:1328-1330.

72.  Schumacher-Feero LA, Yoo KW, Solari FM, et al. Third cranial nerve palsy in children. Am J Ophthalmol. 1999;128:216-221.

73.  Green WR, Hackett ER, Schlezinger NS. Neuro-ophthalmologic evaluation of oculomotor nerve paralysis. Arch Ophthalmol. 1964;72:154-167.

74.  Katusic S, Beard CM, Bergstralth E, et al. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol. 1990;27:89-95.

75.  Olney RK. Neuropathies associated with connective tissue disease. Semin Neurol. 1998;18:63-72.

76.  Korzec K, Sobol SM, Kubal W, et al. Gadolinium-enhanced magnetic resonance imaging of the facial nerve in herpes zoster oticus and Bell's palsy: clinical implications. Am J Otol. 1991;12:163-168.

77.  Gilliatt RW, Taylor JC. Electrical changes following section of the facial nerve. Proc R Soc Med. 1959;52:1080-1083.

78.  Rapana A, Lamaida E, Bracale C, et al. Glossopharyngeal schwannoma, an uncommon posterior fossa tumor: diagnostical and therapeutical aspects: a case report. Clin Neurol Neurosurg. 1997;99:196-198.

79.  Campbell WW. DeJong's the neurologic examination. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.

使用此内容应接受我们的免责声明